Shopping Cart
Remove All
Your shopping cart is currently empty
Briakinumab
😃Good
Catalog No. T76935Cas No. 339308-60-0
Alias J 695, BSF415977, BSF 415977, ABT-874, ABT874, A-796874.0
Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the study of psoriasis, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
Briakinumab
Briakinumab
😃Good
Catalog No. T76935Alias J 695, BSF415977, BSF 415977, ABT-874, ABT874, A-796874.0Cas No. 339308-60-0
Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the study of psoriasis, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $228 | In Stock | In Stock | |
| 5 mg | $562 | In Stock | In Stock | |
| 10 mg | $845 | - | In Stock | |
| 25 mg | $1,250 | - | In Stock | |
| 50 mg | $1,680 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.53% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the study of psoriasis, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. |
| Targets&IC50 | FcRn:0.27 μM (Kd) |
| In vitro | The affinity of Briakinumab to FcRn was Kd = 0.27μM. [1] |
| In vivo | Administering Briakinumab to FcRn knockout (KO) mice via a tail vein, the Briakinumab treated group showed faster clearance compared to wild-type mice. [1] |
| Synonyms | J 695, BSF415977, BSF 415977, ABT-874, ABT874, A-796874.0 |
| Reactivity | Human |
| Verified Activity | Immobilized Human IL-12 p35 (N-His) & IL-12 p40 Protein at 2 μg/mL (30 μL/well) can bind Briakinumab. The EC50 is 3.074 ng/mL.  |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IL-12 |
| Molecular Weight | 143.86 kDa |
| Cas No. | 339308-60-0 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 lambda2 |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Briakinumab | purchase Briakinumab | Briakinumab cost | order Briakinumab | Briakinumab in vivo | Briakinumab in vitro | Briakinumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.